Hypothesis Colonic senescent fibroblasts drive age‑related gut barrier leakiness, which amplifies dysbiotic signaling to the brain via vagal and humoral routes; clearing these cells with a senolytic restores barrier function, normalizes the microbiota‑brain axis, and improves cognition.
Mechanistic Rationale Aging microbiota loses SCFA producers and gains pro‑inflammatory taxa[1]. This shift alone does not fully explain the magnitude of systemic inflammation observed. Recent work shows that senescent stromal cells in the colonic lamina propria secrete SASP factors (IL-6, MMP-9) that disrupt tight junction proteins[2]. The resulting barrier breach allows luminal LPS and microbial metabolites to reach systemic circulation, activating brain microglia through TLR4 and vagal afferents[3]. Thus, the microbiome ages the host, but the host’s senescent stroma determines how strongly that signal is transmitted.
Novel Insight We propose that the senescent fibroblast compartment is the 'hardware' limit that gates microbiome‑derived inflammaging. Even a youthful microbiota cannot provoke neuroinflammation if the barrier is intact; conversely, a pro‑inflammatory microbiota has limited impact when senescent cells are removed.
Testable Predictions
- Aged mice treated with a fibroblast‑specific senolytic (e.g., FOXO4-DRI conjugated to a fibroblast‑targeting peptide) will show ↓ colonic p16^INK4a^+ cells, ↑ zonulin-1 and occludin expression, and reduced serum LPS-binding protein.
- Microbiota composition (16S rRNA sequencing) will remain aged‑like, yet serum cytokine pro





























